Last checked at IN BRIEF: Seneca Growth Profits From Scancell, Omega Share Sales
IN BRIEF: Seneca Growth Profits From Scancell, Omega Share Sales
16 Sep 20 22:16
- Home
- Share Prices
- AQSE Share Prices
- Share Chat
- FX
- News
- Blogs
- RNS
- Media
- Brokers
- Finance Tools
- Members
Latest Share Chat
Scancell Holdings Share News (SCLP)
SCLP Share
Price
SCLP Share
News
SCLP Share
Chat56
SCLP Share
Trades68
SCLP
Live RNS
SCLP Share
Charts
SCLP Level 2
Console
SCLP Live
Share Price
SCLP Broker
Ratings
SCLP Directors
Deals
SCLP Financial
Diary
SCLP
Fundamentals
SCLP Short
Positions
SCLP
Media
SCLP Information
Share Price Information for Scancell Holdings (SCLP)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
14.50
Bid:
14.25
Ask:
14.75
Change:
1.625
(12.62%)
Spread:
0.50 (3.51%)
Open:
12.90
High:
14.625
Low:
12.75
Yest. Close:
12.875
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.16 Sep 20 22:16Scancell Consortium Gets Innovate UK Funding For Covid Vaccine Trial
Scancell Consortium Gets Innovate UK Funding For Covid Vaccine Trial
27 Aug 20 11:16Scancell Raises GBP15 Million To Fund Covid-19 Vaccine Development
Scancell Raises GBP15 Million To Fund Covid-19 Vaccine Development
11 Aug 20 16:18IN BRIEF: Scancell Secures GBP2 Million From Placing
IN BRIEF: Scancell Secures GBP2 Million From Placing
22 Jul 20 20:43IN BRIEF: Scancell To Raise GBP15 Million Via Share, Loan Note Issue
IN BRIEF: Scancell To Raise GBP15 Million Via Share, Loan Note Issue
22 Jul 20 11:24Scancell To Start Clinical Trial For Cancer Treatment In 2021
Scancell To Start Clinical Trial For Cancer Treatment In 2021
24 Jun 20 12:18Scancell upbeat on publication of AvidiMab research
(Sharecast News) - Cancer immunotherapy developer Scancell Holdings noted the publication of its manuscript in Cancer Research, a journal of the American Association of Cancer Research (AACR) on Friday, titled 'Engineering the human Fc-region enables direct cell killing by cancer glycan-targeting antibodies without the need for immune effector cells or complement'.
12 Jun 20 12:59Director dealings: Scancell director lowers stake
(Sharecast News) - Scancell revealed on Tuesday that non-executive director Martin Diggle had sold 1.5m ordinary shares in the AIM-listed biotechnology firm.
28 Apr 20 16:40UK DIRECTOR DEALINGS SUMMARY: Citrus Buys More easyHotel At Exit Price
UK DIRECTOR DEALINGS SUMMARY: Citrus Buys More easyHotel At Exit Price
28 Apr 20 14:43Scancell Rises On Launch Of Covid-19 Vaccine Research Programme
Scancell Rises On Launch Of Covid-19 Vaccine Research Programme
24 Apr 20 12:00UK WINNERS & LOSERS SUMMARY: FirstGroup Rises On Liquidity Boost
UK WINNERS & LOSERS SUMMARY: FirstGroup Rises On Liquidity Boost
24 Apr 20 10:49Scancell's 'SCIB1' clears latest regulatory hurdle in US
(Sharecast News) - Cancer immunotherapy developer Scancell announced on Monday that its investigational new drug (IND) application to the United States Food and Drug Administration (FDA) for 'SCIB1' has been approved.
3 Feb 20 14:20Scancell Gets US FDA Approval For SCIB1 Drug Application
Scancell Gets US FDA Approval For SCIB1 Drug Application
3 Feb 20 10:44Scancell Interim Loss Narrows, Progresses On Product Pipeline
Scancell Interim Loss Narrows, Progresses On Product Pipeline
31 Jan 20 11:12Scancell Teams To Evaluate Its Antibody Platform For Cancer Treatment
Scancell Teams To Evaluate Its Antibody Platform For Cancer Treatment
20 Jan 20 12:04